HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COMMON STOCK-FO
Total 13F shares
202,906,893
Share change
+2,014,865
Total reported value
$14,848,395,953
Put/Call ratio
33%
Price per share
$73.15
Number of holders
484
Value change
+$122,934,582
Number of buys
265
Number of sells
222

Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q4 2020

As of 31 Dec 2020, HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) was held by 484 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 202,906,893 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Avoro Capital Advisors LLC, JANUS HENDERSON GROUP PLC, PAULSON & CO. INC., RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and STATE STREET CORP. This page lists 484 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.